Filtros : "Dantas, V.G.L." Limpar

Filtros



Refine with date range


  • Source: Posters: Cytogenetics. Conference titles: Annual Meeting of the American Society of Human Genetics. Unidade: IB

    Subjects: PERDA AUDITIVA, GENÉTICA MÉDICA, CITOGENÉTICA

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FREITAS, E.L. et al. Whole-genome array-CGH screening in patients with autosomal dominant sensorineural hearing loss points to novel susceptibility loci. 2012, Anais.. São Francisco: Instituto de Biociências, Universidade de São Paulo, 2012. Disponível em: http://www.ashg.org/2012meeting/pdf/38731_poster_complete.pdf. Acesso em: 06 nov. 2024.
    • APA

      Freitas, E. L., Uehara, D. T., Dantas, V. G. L., Silva, A. G., Krepischi, A. C. V., Mingroni Netto, R. C., & Rosenberg, C. (2012). Whole-genome array-CGH screening in patients with autosomal dominant sensorineural hearing loss points to novel susceptibility loci. In Posters: Cytogenetics. São Francisco: Instituto de Biociências, Universidade de São Paulo. Recuperado de http://www.ashg.org/2012meeting/pdf/38731_poster_complete.pdf
    • NLM

      Freitas EL, Uehara DT, Dantas VGL, Silva AG, Krepischi ACV, Mingroni Netto RC, Rosenberg C. Whole-genome array-CGH screening in patients with autosomal dominant sensorineural hearing loss points to novel susceptibility loci [Internet]. Posters: Cytogenetics. 2012 ;[citado 2024 nov. 06 ] Available from: http://www.ashg.org/2012meeting/pdf/38731_poster_complete.pdf
    • Vancouver

      Freitas EL, Uehara DT, Dantas VGL, Silva AG, Krepischi ACV, Mingroni Netto RC, Rosenberg C. Whole-genome array-CGH screening in patients with autosomal dominant sensorineural hearing loss points to novel susceptibility loci [Internet]. Posters: Cytogenetics. 2012 ;[citado 2024 nov. 06 ] Available from: http://www.ashg.org/2012meeting/pdf/38731_poster_complete.pdf

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024